首頁 > 市場調查報告書 > 製藥

循環系統

市場調查報告書

商品編碼

1417204

中風管理市場報告：2030 年趨勢、預測與競爭分析

Stroke Management Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: 2024年01月29日 | 出版商:

Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

卒中管理的趨勢和預測

預計到 2030 年，全球卒中管理市場將達到 651.4 億美元，2024 年至 2030 年年複合成長率為 8.5%。該市場的主要驅動力是人口老化的加劇、心臟疾病和高血壓患者數量的增加以及中風診斷方法的技術進步。全球中風管理市場的未來看起來充滿希望，缺血性中風和出血性中風市場充滿機會。

中風管理市場洞察

Lucintel 預計，由於大眾對中風疾病早期診斷的了解增加，導致中風診斷數量增加，診斷在預測期內將出現最高成長。

由於醫療費用增加和可支配收入增加，亞太地區預計在預測期內將出現最高成長。

常問問題

Q.1 中風管理的市場規模有多大？

A1. 到 2030 年，全球卒中管理市場預計將達到 651.4 億美元。

Q.2 中風管理市場的成長預測為何：

A2. 2024年至2030年，全球中風管理市場預計年複合成長率為8.5%。

Q.3 影響中風管理市場成長的關鍵因素有哪些：

A3. 該市場的主要驅動力是人口老化、心臟疾病和高血壓患者數量的增加以及中風診斷方法的技術進步。

Q4.市場的主要細分市場是：

A4. 中風管理市場的未來前景廣闊，缺血性中風和出血性中風市場充滿機會。

Q5.市場的主要企業是：

A5.以下是主要的中風管理公司。

B Braun Melsungen
Cardinal Health
Medtronic
Bristol Myers Squibb
Boston Scientific Corporation
Abbott Laboratories
General Electric Company
Merck
Siemens
Glaxosmithkline

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預計，由於公眾對中風疾病早期診斷的了解增加，導致中風診斷數量增加，診斷在預測期內將出現最高成長。

Q7. 未來五年預計哪些地區的市場成長最大？

A7. 由於醫療保健成本上升和可支配收入增加，亞太地區預計在預測期內將出現最高成長。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

成長機會分析
- 按類型分類的全球中風管理市場成長機會
- 全球中風管理市場成長機會（按應用）
- 按地區分類的全球中風管理市場成長機會
全球卒中管理市場的新興趨勢
戰略分析
- 新產品開發
- 全球中風管理市場的產能擴張
- 全球卒中管理市場的合併、收購和合資企業
- 認證和許可

第7章主要企業概況

B Braun
Cardinal Health
Medtronic
Bristol Myers Squibb
Boston Scientific Corporation
Abbott Laboratories
General Electric Company
Merck
Siemens
NeuraSignal

簡介目錄

Stroke Management Trends and Forecast

The future of the global stroke management market looks promising with opportunities in the ischemic stroke and hemorrhagic stroke markets. The global stroke management market is expected to reach an estimated $65.14 billion by 2030 with a CAGR of 8.5% from 2024 to 2030. The major drivers for this market are rise in the population's aging, growing number of individuals suffering from coronary heart disease and hypertension, and advancements in technology for stroke diagnosis methods.

A more than 150-page report is developed to help in your business decisions.

Stroke Management by Segment

The study includes a forecast for the global stroke management by type, application, and region.

Stroke Management Market by Type [Shipment Analysis by Value from 2018 to 2030]:

Diagnostics
Therapeutics
Software

Stroke Management Market by Application [Shipment Analysis by Value from 2018 to 2030]:

Ischemic Stroke
Hemorrhagic Stroke

Stroke Management Market by Region [Shipment Analysis by Value from 2018 to 2030]:

North America
Europe
Asia Pacific
The Rest of the World

List of Stroke Management Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies stroke management companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the stroke management companies profiled in this report include-

B Braun
Cardinal Health
Medtronic
Bristol Myers Squibb
Boston Scientific Corporation
Abbott Laboratories
General Electric Company
Merck
Siemens
Neurasignal

Stroke Management Market Insights

Lucintel forecasts that diagnostics is expected to witness highest growth over the forecast period due to rise in stroke diagnoses as a result of increased public knowledge of early stroke illness diagnosis.

APAC is expected to witness highest growth over the forecast period due to growth in healthcare costs combined with an increase in disposable income.

Features of the Global Stroke Management Market

Market Size Estimates: Stroke management market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Stroke management market size by type, application, and region in terms of value ($B).

Regional Analysis: Stroke management market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the stroke management market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the stroke management market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the stroke management market size?

Answer: The global stroke management market is expected to reach an estimated $65.14 billion by 2030.

Q.2 What is the growth forecast for stroke management market?

Answer: The global stroke management market is expected to grow with a CAGR of 8.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the stroke management market?

Answer: The major drivers for this market are rise in the population's aging, growing number of individuals suffering from coronary heart disease and hypertension, and advancements in technology for stroke diagnosis methods.

Q4. What are the major segments for stroke management market?

Answer: The future of the stroke management market looks promising with opportunities in the ischemic stroke and hemorrhagic stroke markets.

Q5. Who are the key stroke management market companies?

Answer: Some of the key stroke management companies are as follows.

B Braun Melsungen
Cardinal Health
Medtronic
Bristol Myers Squibb
Boston Scientific Corporation
Abbott Laboratories
General Electric Company
Merck
Siemens
Glaxosmithkline

Q6. Which stroke management market segment will be the largest in future?

Answer: Lucintel forecasts that diagnostics is expected to witness highest growth over the forecast period due to rise in stroke diagnoses as a result of increased public knowledge of early stroke illness diagnosis.

Q7. In stroke management market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to growth in healthcare costs combined with an increase in disposable income.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the stroke management market by type (diagnostics and therapeutics), application (ischemic stroke and hemorrhagic stroke), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

1. Executive Summary

2. Global Stroke Management Market : Market Dynamics

2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Stroke Management Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Stroke Management Market by Type
- 3.3.1: Diagnostics
- 3.3.2: Therapeutics
- 3.3.3: Software
3.4: Global Stroke Management Market by Application
- 3.4.1: Ischemic Stroke
- 3.4.2: Hemorrhagic Stroke

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

4.1: Global Stroke Management Market by Region
4.2: North American Stroke Management Market
- 4.2.2: North American Stroke Management Market by Application: Ischemic Stroke and Hemorrhagic Stroke
4.3: European Stroke Management Market
- 4.3.1: European Stroke Management Market by Type: Diagnostics, Therapeutics, and Software
- 4.3.2: European Stroke Management Market by Application: Ischemic Stroke and Hemorrhagic Stroke
4.4: APAC Stroke Management Market
- 4.4.1: APAC Stroke Management Market by Type: Diagnostics, Therapeutics, and Software
- 4.4.2: APAC Stroke Management Market by Application: Ischemic Stroke and Hemorrhagic Stroke
4.5: ROW Stroke Management Market
- 4.5.1: ROW Stroke Management Market by Type: Diagnostics, Therapeutics, and Software
- 4.5.2: ROW Stroke Management Market by Application: Ischemic Stroke and Hemorrhagic Stroke

5. Competitor Analysis

5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

6.1: Growth Opportunity Analysis
- 6.1.1: Growth Opportunities for the Global Stroke Management Market by Type
- 6.1.2: Growth Opportunities for the Global Stroke Management Market by Application
- 6.1.3: Growth Opportunities for the Global Stroke Management Market by Region
6.2: Emerging Trends in the Global Stroke Management Market
6.3: Strategic Analysis
- 6.3.1: New Product Development
- 6.3.2: Capacity Expansion of the Global Stroke Management Market
- 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Stroke Management Market
- 6.3.4: Certification and Licensing